TrialRespiratory research2016
A proof-of-concept clinical study examining the NRF2 activator sulforaphane against neutrophilic airway inflammation.
Charity G Duran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it